Exor
Latest statistics and disclosures from Exor's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Amr, Via Transn, CLVT, and represent 100.00% of Exor's stock portfolio.
- Added to shares of these 1 stock: Via Transn (+$679M).
- Started 1 new stock position in Via Transn.
- Exor was a net buyer of stock by $679M.
- Exor has $5.9B in assets under management (AUM), dropping by 26.70%.
- Central Index Key (CIK): 0001589122
Tip: Access up to 7 years of quarterly data
Positions held by Exor consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Exor
Exor holds 3 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Koninklijke Philips N V Ny Regis Shs New | 84.2 | $5.0B | 183M | 27.26 |
|
|
| Via Transn Com Cl A | 11.5 | $679M | NEW | 14M | 48.08 |
|
| Clarivate Ord Shs (CLVT) | 4.4 | $258M | 67M | 3.83 |
|
Past Filings by Exor
SEC 13F filings are viewable for Exor going back to 2022
- Exor 2025 Q3 filed Nov. 12, 2025
- Exor 2025 Q2 filed July 16, 2025
- Exor 2025 Q1 filed May 8, 2025
- Exor 2024 Q4 filed Jan. 22, 2025
- Exor 2024 Q3 filed Oct. 17, 2024
- Exor 2024 Q2 filed July 9, 2024
- Exor 2024 Q1 filed April 16, 2024
- Exor 2023 Q4 filed Feb. 12, 2024
- Exor 2023 Q3 filed Nov. 8, 2023
- Exor 2023 Q2 filed Aug. 14, 2023
- Exor 2023 Q1 filed May 15, 2023
- Exor 2022 Q4 filed Feb. 14, 2023